Company Description
Illumina elucidates the human genome. The firm makes instruments used by life sciences and pharmaceutical researchers to test and analyze genes....
Key Illumina Financials
| Company Type | Public - NASDAQ (GM): ILMN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $366.8 |
| 2007 Employees | 1,041 |
More Illumina Financials (11 pages)
Latest Illumina Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Illumina's competition across multiple industries
Top Illumina Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Illumina Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | William H. (Bill) Rastetter | Network | E-mail |
| President, CEO, and Director | Jay T. Flatley | Network | E-mail |
| SVP, CFO, and Acting General Manager Sequencing | Christian O. Henry | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Illumina News
- Genetics get personal [New Scientist] (05 Jul 2008 00:01:00 EDT)
- Transition Therapeutics Promotes Farah, Rusaw-George [InvesTrend] (04 Jul 2008 00:01:00 EDT)
- Oligonucleotide synthesizer [U.S. Patents] (01 Jul 2008 13:21:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.